| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 4,575,243 | 3,123,778 |
| Increase (decrease) in cash and cash equivalents | -1,828,859 | -1,290,502 |
| Cash and cash equivalents at beginning of period | 3,502,077 | - |
| Cash and cash equivalents at end of period | 1,673,218 | - |
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC)